CD44 and colorectal carcinoma: Our current observation that the proportion of CD44+CD166− in the colonic effluent and in freshly isolated colonic mucosal cells is markedly higher in AAs with adenomas than their Whites counterparts further strengthens our contention that CSCs, specifically the CD44+CD166− phenotype could one of the underlying factors for the increased incidence of CRC in AAs.